SCHEMBL39026

SCHEMBL39026

CCOC(=O)c1cc(O)cc(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 7/20 1.00
CA1 P00915 7/20 1.00
CA2 P00918 7/20 1.00
CA7 P43166 7/20 1.00
CA9 Q16790 7/20 1.00
CA14 Q9ULX7 7/20 1.00
ESR1 P03372 3/20 0.64
ESR2 Q92731 1/20 0.64
NR1H2 P55055 1/20 0.62
NR1H3 Q13133 1/20 0.62
CYP3A4 P08684 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
LMNA P02545 1/20 0.52
CYP1A2 P05177 1/20 0.52
MAOA P21397 1/20 0.52
HSD17B2 P37059 1/20 0.51
BCL2L1 Q07817 1/20 0.50
ALDH1A1 P00352 1/20 0.50
CHRM1 P11229 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL475700 0.96 CA12 (0.92) CA12CA1CA2CA7CA9
SCHEMBL2257945 0.90 CA12 (0.81) CA12CA1CA2CA7CA9
SCHEMBL20377203 0.90 CA12 (0.81) CA12CA1CA2CA7CA9
SCHEMBL29762017 0.90 CA12 (0.81) CA12CA1CA2CA7CA9
SCHEMBL2208614 0.88 CA12 (0.79) CA12CA1CA2CA7CA9
SCHEMBL57016 0.88 CA12 (0.79) CA12CA1CA2CA7CA9
SCHEMBL6264809 0.87 CA12 (0.76) CA12CA1CA2CA7CA9
SCHEMBL1664013 0.86 CA12 (0.75) CA12CA1CA2CA7CA9
SCHEMBL14374036 0.85 CA12 (0.73) CA12CA1CA2CA7CA9
SCHEMBL5415007 0.85 CA12 (0.73) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680027-A1 A METHOD FOR IMPARTING ANTIMICROBIAL PROPERTIES TO A SYNTHETIC SUBSTRATE Biocompatibility Innovation Srl (IT) 2026-01-21 EP claimed
WO-2024209462-A1 ANTI-BIOFILM POLYMER COMPOSITIONS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-10-10 WO claimed
WO-2024189407-A1 A METHOD FOR IMPARTING ANTIMICROBIAL PROPERTIES TO A SYNTHETIC SUBSTRATE Biocompatibility Innovation S.r.l. (IT) 2024-09-19 WO claimed
CN-114805067-B Preparation method of prohexadione calcium intermediate 浙江科技学院 2024-07-05 CN claimed
EP-4144217-A1 ANTIMICROBIAL COMPOSITION FOR HARD SURFACES Viraschutz Europe S.r.l. (IT) 2023-03-08 EP claimed
EP-3320018-B1 POLYCARBONATE COMPOSITIONS WITH IMPROVED FLAME RETARDANCE SHPP GLOBAL TECH BV (NL) 2022-08-10 EP claimed
CN-114805067-A Preparation method of prohexadione calcium intermediate 浙江科技学院 2022-07-29 CN claimed
WO-2022072394-A1 CURABLE COATING COMPOSITIONS AND ANTIMICROBIAL/ANTIVIRAL COATINGS MADE BY CURING SUCH COATING COMPOSITIONS GREEN THEME TECHNOLOGIES, INC. (US) 2022-04-07 WO claimed
US-20220098418-A1 CURABLE COATING COMPOSITIONS AND ANTIMICROBIAL COATINGS MADE BY CURING SUCH COATING COMPOSITIONS GREEN THEME TECHNOLOGIES, INC. 2022-03-31 US claimed
US-10597530-B2 Polycarbonate compositions with improved flame retardance SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2020-03-24 US claimed
US-20180223097-A1 POLYCARBONATE COMPOSITIONS WITH IMPROVED FLAME RETARDANCE SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2018-08-09 US claimed
EP-3320018-A1 POLYCARBONATE COMPOSITIONS WITH IMPROVED FLAME RETARDANCE SABIC Global Technologies B.V. (NL) 2018-05-16 EP claimed
CN-107849229-A Polycarbonate compositions with improved anti-flammability 沙特基础工业全球技术有限公司 2018-03-27 CN claimed
WO-2017007562-A1 POLYCARBONATE COMPOSITIONS WITH IMPROVED FLAME RETARDANCE SABIC GLOBAL TECHNOLOGIES B. V. (NL) 2017-01-12 WO claimed
US-20150343569-A1 SN-AG-CU-BASED SOLDER POWDER AND SOLDER PASTE USING SAID POWDER MITSUBISHI MATERIALS CORPORATION (JP) 2015-12-03 US claimed
EP-2567675-A2 BONE-TRANSPLANT OR BONE-FILLING COMPOSITION COMPRISING A DIHYDROXYBENZOIC ACID DERIVATIVE Cellsafe Co. Ltd. (KR) 2013-03-13 EP claimed
US-20130053354-A1 BONE-TRANSPLANT OR BONE-FILLING COMPOSITION COMPRISING A DIHYDROXYBENZOIC ACID DERIVATIVE CELLSAFE CO., LTD. (KR) 2013-02-28 US claimed
EP-1041448-B1 Method for decoloring TOSHIBA KK (JP) 2006-06-07 EP claimed
US-6326332-B1 HEATING KABUSHIKI KAISHA TOSHIBA (JP) 2001-12-04 US claimed
EP-1041448-A1 Decolorable material and method for decoloring the same Kabushiki Kaisha Toshiba (JP) 2000-10-04 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053354-A1 BONE-TRANSPLANT OR BONE-FILLING COMPOSITION COMPRISING A DIHYDROXYBENZOIC ACID DERIVATIVE BMP2, BMP6, BMP4 CA12 4301/4885CA1 3031/4885CA2 3575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.